These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 2117624

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
    Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA.
    Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.
    Vinores SA, Van Niel E, Swerdloff JL, Campochiaro PA.
    Histochem J; 1993 Sep; 25(9):648-63. PubMed ID: 8226103
    [Abstract] [Full Text] [Related]

  • 5. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
    Lightman S, Rechthand E, Terubayashi H, Palestine A, Rapoport S, Kador P.
    Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
    [Abstract] [Full Text] [Related]

  • 6. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
    Greenwood J, Howes R, Lightman S.
    Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
    [Abstract] [Full Text] [Related]

  • 7. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
    Do carmo A, Ramos P, Reis A, Proença R, Cunha-vaz JG.
    Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
    [Abstract] [Full Text] [Related]

  • 8. Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3175-7. PubMed ID: 1748548
    [Abstract] [Full Text] [Related]

  • 9. Significance of outer blood-retina barrier breakdown in diabetes and ischemia.
    Xu HZ, Le YZ.
    Invest Ophthalmol Vis Sci; 2011 Apr 05; 52(5):2160-4. PubMed ID: 21178141
    [Abstract] [Full Text] [Related]

  • 10. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K.
    Lab Invest; 1996 Apr 05; 74(4):819-25. PubMed ID: 8606491
    [Abstract] [Full Text] [Related]

  • 11. The blood-retinal barriers.
    Cunha-Vaz JG.
    Doc Ophthalmol; 1976 Oct 15; 41(2):287-327. PubMed ID: 1009819
    [Abstract] [Full Text] [Related]

  • 12. Lanthanum and freeze-fracture studies of retinal pigment epithelial cell junctions in the streptozotocin diabetic rat.
    Caldwell RB, Slapnick SM, McLaughlin BJ.
    Curr Eye Res; 1985 Mar 15; 4(3):215-27. PubMed ID: 3160541
    [Abstract] [Full Text] [Related]

  • 13. Impact of Cationic Amino Acid Transporter 1 on Blood-Retinal Barrier Transport of L-Ornithine.
    Kubo Y, Obata A, Akanuma S, Hosoya K.
    Invest Ophthalmol Vis Sci; 2015 Sep 15; 56(10):5925-32. PubMed ID: 26377079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.
    Luna JD, Chan CC, Derevjanik NL, Mahlow J, Chiu C, Peng B, Tobe T, Campochiaro PA, Vinores SA.
    J Neurosci Res; 1997 Aug 01; 49(3):268-80. PubMed ID: 9260738
    [Abstract] [Full Text] [Related]

  • 16. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG, Pugliese G, LaRose LS, Faller AM, Chang K, Province MA, Williamson JR.
    J Diabet Complications; 1991 Aug 01; 5(4):230-7. PubMed ID: 1779018
    [Abstract] [Full Text] [Related]

  • 17. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
    Engerman RL, Kern TS.
    Diabetes; 1993 Jun 01; 42(6):820-5. PubMed ID: 8495805
    [Abstract] [Full Text] [Related]

  • 18. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A, Frank RN, Zhang NL, Samadani E.
    Exp Eye Res; 1990 Mar 01; 50(3):269-80. PubMed ID: 2108050
    [Abstract] [Full Text] [Related]

  • 19. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition.
    Engerman RL, Kern TS, Garment MB.
    J Diabetes Complications; 1993 Mar 01; 7(4):241-5. PubMed ID: 8219367
    [Abstract] [Full Text] [Related]

  • 20. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of retinal tissues in a streptozotocin-induced diabetic rat model.
    Akita M, Mizuno K, Matsubara A, Nakano K, Kurono M.
    Acta Med Okayama; 1993 Oct 01; 47(5):299-304. PubMed ID: 8273453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.